743015
Last Update Posted: 2013-11-01
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
19 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
The general aim is to evaluate the relative oral bioavailability of BI 44370 TA tablets during and between migraine attacks as well as Safety, Tolerability and Pharmacokinetic
Eligibility
Relevant conditions:
Migraine Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov